COMPASS PATH SP ADR (CMPS)

Despite the stigma surrounding psychedelics for personal use, controlled medical experiments indicate their usefulness for treating a variety of conditions.

The 3 Best Psychedelic Stocks to Buy Now

By Alex Sirois, InvestorPlace Contributor Jun 29, 2023

Psychedelic stocks promise to bring therapeutics to market that were taboo until recently and have huge upside.

7 Long-Term Stocks to Buy With Your Tax Refund

By Josh Enomoto, InvestorPlace Contributor Feb 12, 2023

Although you might want to spend your tax refund, a better approach is to target compelling long-term stocks to buy.

7 Tempting Sin Stocks to Buy for Promising Profits

By Josh Enomoto, InvestorPlace Contributor Feb 6, 2023

After a rough time in 2022, investors may want to consider sin stocks to buy for a cynical shot at significant upside potential.

The 7 Most Promising Psychedelic Stocks to Buy in February

By Muslim Farooque, InvestorPlace Contributor Feb 5, 2023

These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector.

Compass Pathways (CMPS): The McDonald’s of Psychedelics?

By Luke Lango, InvestorPlace Senior Investment Analyst Sep 6, 2022

This week, we’re talking about my Big Three investing themes for the rest of the year (and beyond), which includes a psychedelic stock favorite, Compass Pathways (CMPS).

7 Psychedelics Stocks to Buy for a Big Drug Boom

By Tezcan Gecgil, InvestorPlace Contributor Aug 30, 2022

These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, GHRS and MNMD can make great investments

3 Best Psychedelic Stocks to Buy Now

By Muslim Farooque, InvestorPlace Contributor Aug 9, 2022

These are three of the best psychedelic stocks to buy to get in on the next generation of treatment for mental health disorders.

Dear Psychedelic Stocks Fans, Watch This Key Catalyst

By Bret Kenwell, InvestorPlace Contributor Jul 21, 2022

Psychedelic stocks are in focus following new legislation from both the Senate and the House that has bipartisan support.

Growing Psychedelic Interest Will Help Push Compass Pathways Stock Up 3X By 2022

By Luke Lango and the InvestorPlace Research Staff Aug 4, 2021

By 2030, psychedelic therapy will be the gold standard for mental health treatment. And Compass is at the forefront of commercialization.

7 Stocks to Buy if You Think Alternative Therapies Are the Future

By Josh Enomoto, InvestorPlace Contributor Aug 2, 2021

Here are seven stocks to buy if you're optimistic about the potential for alternative therapies to become mainstream treatments.

What Will the Stock Market Do Today? 3 Big Stories to Watch.

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Jul 2, 2021

So what will the stock market do today? All eyes are on Richard Branson as the space race between him and Jeff Bezos heats up.

3 Psychedelics Stocks Getting High Thanks to the Newly Launched PSY ETF

By Muslim Farooque, InvestorPlace Contributor Jun 15, 2021

These psychedelic stocks have compelling product pipelines and have built up a great head of steam in the past month thanks to the PSY ETF.

Compass Pathways Offers Chance on Exploratory Mental Health Treatments

By David Moadel, InvestorPlace Contributor May 18, 2021

Over the past year, CMPS stock has been going nowhere fast. However, there's been recent progress in advancing psilocybin-assisted therapy.

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

By Sarah Smith, Editor-in-Chief, InvestorPlace.com May 17, 2021

So what did the stock market do today? All eyes were on Bitcoin prices, EV stocks and hype in the psychedelics market.

3 Top Psychedelic Stocks to Own Now

By Ian Cooper, InvestorPlace Contributor May 6, 2021

Psychedelics could be a game-changer for millions struggling with mental health. Here are some of the top ways to trade psychedelic stocks.

MNMD Stock: A MindMed Buzz Kill as the Psychedelic Shares Tank on First Day of Trading

By William White, InvestorPlace Writer Apr 27, 2021

MindMed (MNMD) stock isn't doing so hot with shares taking a beating on the first day of trading at their new home on the Nasdaq.

COMPASS PATH SP ADR (CMPS)

3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers

3 Psychedelic Stocks to Buy on the Dip: Summer 2024

CMPS Stock Earnings: Compass Pathways Misses EPS for Q1 2024

Penny Power Players: 3 Stocks to Watch in the Microcap Arena

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

COMPASS PATH SP ADR (CMPS)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

CMPS Stock Predictions, Articles, and COMPASS PATH SP ADR News

Subscriber Sign in